U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H22O3
Molecular Weight 298.3762
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of AURAPTENE

SMILES

CC(C)=CCC\C(C)=C\COC1=CC=C2C=CC(=O)OC2=C1

InChI

InChIKey=RSDDHGSKLOSQFK-RVDMUPIBSA-N
InChI=1S/C19H22O3/c1-14(2)5-4-6-15(3)11-12-21-17-9-7-16-8-10-19(20)22-18(16)13-17/h5,7-11,13H,4,6,12H2,1-3H3/b15-11+

HIDE SMILES / InChI

Molecular Formula C19H22O3
Molecular Weight 298.3762
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Description

Auraptene (7-Geranyloxycoumarin) is the best known and most abundant prenyloxycoumarin present in nature. It is synthesized by various plant species, mainly those of the Rutaceae and Umbelliferae (Apiaceae) families, comprising many edible fruits and vegetables such as lemons, grapefruit, and orange. Auraptene has shown a remarkable effect in the prevention of degenerative diseases, in particular, it has been reported to be one the most promising known natural chemopreventive agents against several types of cancer. The effect in humans is not yet known.

CNS Activity

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
23.9 µM [IC50]
345.1 µM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown
Primary
Unknown
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
Auraptene was administrated to rats for 28 days by oral gavage in doses of 125 and 250 mg/kg.
Route of Administration: Oral
In Vitro Use Guide
HT29 cells were used for activity evaluation. To study the cytotoxicity of auraptene in combination with chemotherapy or ionizing radiation, thiazolyl blue (MTT) assay was used. In this regard, MTT dye (Atocel, Budapest, Hungary) was dissolved in phosphate-buffered saline (PBS; 5 mg/mL) and added to each well (20 μL/well) by the end of treatments. Afterwards, plates were incubated for 4 h at 37°C, and then medium was replaced by DMSO (150 μL/well) to dissolve produced formazan crystals, and finally, optic densities of wells were measured spectrophotometrically at 570 nm using an ELISA plate reader (Awareness Connecticut, USA).
Substance Class Chemical
Record UNII
F79I1ZEL2E
Record Status Validated (UNII)
Record Version